HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanol

an insulin-like growth factor I receptor (IGFIR) tyrosine kinase inhibitor
Also Known As:
OSI 906; OSI-906; OSI906; linsitinib
Networked: 80 relevant articles (11 outcomes, 24 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Poondru, Srinivasu: 8 articles (01/2018 - 02/2015)
2. Okuyama, Tomoko: 4 articles (10/2020 - 06/2014)
3. Shirakawa, Jun: 4 articles (10/2020 - 06/2014)
4. Terauchi, Yasuo: 4 articles (10/2020 - 06/2014)
5. Togashi, Yu: 4 articles (10/2020 - 06/2014)
6. Eckhardt, S Gail: 4 articles (12/2018 - 11/2010)
7. Chen, Jihong: 4 articles (01/2018 - 04/2015)
8. Buck, Elizabeth: 4 articles (02/2012 - 09/2009)
9. Kyohara, Mayu: 3 articles (10/2020 - 01/2017)
10. Tajima, Kazuki: 3 articles (10/2020 - 01/2017)

Related Diseases

1. Neoplasms (Cancer)
2. Colorectal Neoplasms (Colorectal Cancer)
3. Esophageal Squamous Cell Carcinoma
4. Ewing Sarcoma (Sarcoma, Ewing)
5. Prostatic Neoplasms (Prostate Cancer)

Related Drugs and Biologics

1. Insulin Receptor
2. Gefitinib (Iressa)
3. IGF Type 1 Receptor (IGF 1 Receptor)
4. Phosphotransferases (Kinase)
5. Somatomedin Receptors (Somatomedin Receptor)
6. Tyrosine Kinase Inhibitors
7. Biomarkers (Surrogate Marker)
8. Proteins (Proteins, Gene)
9. Insulin-Like Peptides
10. Irinotecan (Camptosar)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Castration
3. Therapeutics
4. Intraperitoneal Injections